2Yang E, ZlmJ, Jokd J, etai. Bad, a heterodimeric partner for bcl- Xt and bcl - 2, displaces bax and promotes cell death. Cell, 1995, 80(2) :285 - 292.
3Hruby G, Barton M, Miles S, et al. Sites of local recurrence after Surgery, with or without chemotherapy, for rectal cancer: implications for radiotherapy field design.Int J Radiat Oncol Biol Phys,2003,55(1) :138-143.
4Wadler S. Systemic treatment of advanced colorectal cancer:Incorporating new agents into the therapentic strate-Gy. Seminars Colon Rectal Surgery, 2002, 13 (4): 269-276.
5Macurer CA, Borner M, Buchler MW. Region al chemotherapy of gastro? interstinal cancer. Digestive Surgery,1997,154(8) :9-22.
6Hasegawn M, Yamakama M, Mitsuhashi N, et al. Immunohistochemical study of radioation-induced apoptosis and oncogehea. Nippon Igak Hoshasen Gakkai Z asshi, 1995,55(7):779.
7Kapiteijin E, Marijinen CA, Nagtegal ID, et al. preoperative radiotherapy combined with total mesorectal excision for respectable rectal cancer. N Engl J Med, 2001,345(9) :638-646.
8Hao X,Du M,Bishop AE,et al.Imbalance between proliferation and apoptosis in the development of colorectal carcinoma.Virchows Arch,1998,433:523-527.
9Hao XP,Ilyas M,Talbot IC.Expression of Bcl-2 and P53 in the colorectal adenoma-carcinoma sequence.Patholbiology,1997,65:140-145.
10Kikuchi Y,Dinjens WN,Bosman FT.Proliferation and apoptosis in proliferative lesions of the colon and rectum.Virchows Arch,1997,431:111-117.
